IQ-AI Limited (IQAI) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 May 2023 04:14 PM
RNS
Notice of AGM
26 Apr 2023 07:00 AM
RNS
Final Results
28 Feb 2023 03:52 PM
RNS
Orphan Drug Designation Status
13 Jan 2023 02:05 PM
RNS
Second Price Monitoring Extn
13 Jan 2023 02:00 PM
RNS
Price Monitoring Extension
13 Jan 2023 11:05 AM
RNS
Second Price Monitoring Extn
13 Jan 2023 11:00 AM
RNS
Price Monitoring Extension
10 Jan 2023 07:00 AM
RNS
Letter to Shareholders
02 Dec 2022 11:11 AM
RNS
Holding in Company
25 Oct 2022 11:00 AM
RNS
Price Monitoring Extension
30 Sep 2022 07:00 AM
RNS
Letter to Shareholders
26 Sep 2022 07:00 AM
RNS
Issue of Warrants to Employees
16 Aug 2022 04:40 PM
RNS
Second Price Monitoring Extn
16 Aug 2022 04:35 PM
RNS
Price Monitoring Extension
16 Aug 2022 09:28 AM
RNS
Half-year Report
03 Aug 2022 01:01 PM
RNS
TR1 - Notification of Major Holdings
11 Jul 2022 07:00 AM
RNS
Imaging Biometrics Announces Channel Partnership
31 May 2022 11:05 AM
RNS
Second Price Monitoring Extn
31 May 2022 11:00 AM
RNS
Price Monitoring Extension
31 May 2022 08:00 AM
RNS
Submission of FDA 510(k) Application for IB Zero G
30 May 2022 10:47 AM
RNS
Result of AGM
05 May 2022 03:00 PM
RNS
Notice of AGM
03 May 2022 02:21 PM
RNS
IB Broadens Quantitative Mapping
28 Apr 2022 05:52 PM
RNS
Final Results
09 Mar 2022 03:08 PM
RNS
IQAI's Sponsored Phase I Clinical Trial is Open
28 Feb 2022 11:12 AM
RNS
Total Voting Rights
08 Feb 2022 07:00 AM
RNS
Issue of shares to Mayo Clinic
27 Jan 2022 07:00 AM
RNS
Imaging Biometrics LLC - Letter to Shareholders
04 Jan 2022 09:27 AM
RNS
Director/PDMR Shareholding
17 Dec 2021 07:37 AM
RNS
IQ-AI Prepares for Phase I Clinical Trial Launch
13 Dec 2021 10:32 AM
RNS
Director's Interest
11 Nov 2021 08:52 AM
RNS
Agreement with St. Jude Children's Hospital
02 Nov 2021 08:19 AM
RNS
MD ANDERSON ADOPTS IB CLINIC
28 Oct 2021 04:00 PM
RNS
Letter to Shareholders
07 Oct 2021 04:41 PM
RNS
Second Price Monitoring Extn
07 Oct 2021 04:36 PM
RNS
Price Monitoring Extension
07 Oct 2021 02:05 PM
RNS
Second Price Monitoring Extn
07 Oct 2021 02:00 PM
RNS
Price Monitoring Extension
07 Oct 2021 12:00 PM
RNS
Placing
01 Oct 2021 08:17 AM
RNS
Case Report on Clinical Value of IB Software
22 Sep 2021 07:00 AM
RNS
EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING
17 Sep 2021 07:00 AM
RNS
IB Software Chosen for Accuracy and Automation
10 Sep 2021 07:00 AM
RNS
Update on Phase I Clinical Trial
02 Sep 2021 07:00 AM
RNS
Board Changes
01 Sep 2021 10:00 AM
RNS
Start of Trading on the OTCQB Venture Market
27 Aug 2021 09:57 AM
RNS
Half Yearly Report
11 Jun 2021 04:41 PM
RNS
Second Price Monitoring Extn
11 Jun 2021 04:36 PM
RNS
Price Monitoring Extension
11 Jun 2021 02:05 PM
RNS
Second Price Monitoring Extn
11 Jun 2021 02:00 PM
RNS
Price Monitoring Extension

IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on proven technologies. Its geographical segment includes Jersey and the United States of America and reportable segments are holding company expenses and medical software. The company derives a majority of revenue from the United States of America. It also supplies medical technology solutions and has a strong neuroimaging product portfolio.

IQ-AI share price listed in London at 87p in 1996.

UK 100

Latest directors dealings